Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company`s product pipeline includes iStent Infinite for use as a standalone procedure in patients with refractory glaucoma; iStent SA, a two-stent product that is designed for use as a standalone glaucoma procedure; iDose Travoprost, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication; and MicroShunt, an ab-externo device for treatment of open-angle glaucoma. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California.
Website: glaukos.com



Growth: Good revenue growth rate 38.1%, there is acceleration compared to average historical growth rates 18.4%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is negative, -11.5%. On average the margin is improving steadily. Gross margin is high, +78.4%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of -$0.04 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 174.6% higher than minimum and 22.9% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.2x by EV / Sales multiple , the company can be 85.4% overvalued

Insiders: For the last 3 months insiders sold company shares on $37.8 mln (-0.574% of cap.)

Key Financials (Download financials)

Ticker: GKOS
Share price, USD:  (0.0%)124.27
year average price 99.94  


year start price 153.08 2025-02-08

max close price 160.58 2025-02-19

min close price 74.67 2025-10-24

current price 124.27 2026-02-07
Common stocks: 57 398 000

Dividend Yield:  0.0%
EV / Sales: 14.8x
Margin (EBITDA LTM / Revenue): -11.5%
Fundamental value created in LTM:
Market Cap ($m): 7 133
Net Debt ($m): -169
EV (Enterprise Value): 6 964
Price to Book: 9.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-31fool.com

Director Sells GKOS 15,000 Shares for $1.9 Million

2026-01-29zacks.com

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

2026-01-13seekingalpha.com

Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-29zacks.com

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

2025-12-03seekingalpha.com

Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

2025-11-28zacks.com

Here's Why You Should Retain Glaukos Stock in Your Portfolio

2025-10-30seekingalpha.com

Glaukos Corporation (GKOS) Q3 2025 Earnings Call Transcript

2025-09-02zacks.com

Glaukos Builds Dual Growth Engines Amid Market Headwinds

2025-08-01fool.com

Glaukos (GKOS) Q2 Revenue Jumps 30%

2025-07-31zacks.com

GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-31 2025-08-04 2024-11-05 2024-08-02 2024-05-03 2023-11-01 2023-08-02 2023-05-04 2022-11-04
acceptedDate 2025-10-30 18:53:18 2025-08-04 16:56:56 2025-02-24 18:11:53 2024-11-04 17:49:49 2024-08-02 16:44:58 2024-05-02 17:38:19 2024-02-23 17:23:59 2023-11-01 16:38:45 2023-08-02 16:53:09 2023-05-04 16:58:35 2023-02-24 17:27:48 2022-11-03 19:36:19 2022-02-28 16:35:09 2021-03-01 06:14:50
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 134M 124M 383M 97M 96M 86M 315M 78M 80M 74M 283M 71M 294M 225M
costOfRevenue 29M 27M 94M 23M 23M 20M 76M 19M 20M 18M 69M 17M 67M 92M
grossProfit 105M 97M 289M 74M 73M 65M 239M 60M 60M 56M 214M 54M 227M 133M
grossProfitRatio 0.784 0.783 0.766 0.764 0.763 0.763 0.75 0.755 0.763
researchAndDevelopmentExpenses 38M 37M 136M 35M 34M 31M 139M 33M 36M 35M 123M 29M 101M 85M
generalAndAdministrativeExpenses 0 0 259M 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 4M 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 83M 83M 263M 64M 66M 62M 224M 54M 53M 54M 193M 47M 179M 171M
otherExpenses 0 0 13M 0 -2M -1M 5M -2M -2M 528 000 -20M 0 -20M 0
operatingExpenses 121M 120M 412M 99M 101M 93M 368M 88M 89M 89M 296M 76M 260M 257M
costAndExpenses 150M 147M 506M 121M 123M 113M 443M 106M 109M 107M 365M 93M 327M 349M
interestIncome 3M 3M 11M 3M 3M 3M 9M 3M 2M 2M 2M 744 000 1M 2M
interestExpense 6M 1M 10M 2M 3M 3M 14M 3M 3M 3M 14M 3M 13M 14M
depreciationAndAmortization 10M 10M 40M 9M 8M 10M 38M 1M 7M 12M 36M -2M 34M 35M
ebitda -570 000 -9M -96M -11M -30M -17M -82M -27M -22M -21M -49M -24M -1M -84M
ebitdaratio -0.004 -0.07 -0.109 -0.204 -0.203 -0.346 -0.269 -0.291 -0.335
operatingIncome -16M -23M -122M -25M -27M -27M -129M -28M -29M -33M -82M -22M -33M -124M
operatingIncomeRatio -0.123 -0.183 -0.255 -0.287 -0.319 -0.359 -0.362 -0.446 -0.303
totalOtherIncomeExpensesNet 368 000 3M -23M 3M -20M -13M -5M -2M -2M -1M -16M -6M -16M -9M
incomeBeforeTax -16M -19M -146M -21M -50M -40M -134M -30M -32M -34M -98M -27M -49M -132M
incomeBeforeTaxRatio -0.12 -0.156 -0.22 -0.525 -0.473 -0.39 -0.403 -0.463 -0.383
incomeTaxExpense 234 000 248 000 771 000 177 000 331 000 377 000 934 000 37 000 435 000 401 000 766 000 247 000 326 000 -12M
netIncome -16M -20M -146M -21M -51M -41M -135M -30M -33M -35M -99M -28M -50M -120M
netIncomeRatio -0.122 -0.158 -0.221 -0.528 -0.477 -0.39 -0.408 -0.469 -0.387
eps -0.28 -0.34 -2.77 -0.39 -1 -0.82 -2.78 -0.63 -0.68 -0.72 -2.09 -0.58 -1.07 -2.7
epsdiluted -0.28 -0.34 -0.39 -1 -0.82 -0.63 -0.68 -0.72 -0.58
weightedAverageShsOut 57M 57M 53M 55M 51M 50M 48M 49M 48M 48M 47M 48M 46M 44M
weightedAverageShsOutDil 57M 57M 53M 55M 51M 50M 48M 49M 48M 48M 47M 48M 46M 44M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-23 2023-02-24 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 1M -4M -11M -12M -12M
ebit -136M -120M -85M -36M -118M
nonOperatingIncomeExcludingInterest 13M -9M 2M 3M -5M
netIncomeFromContinuingOperations -146M -135M -99M -50M -120M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -146M -135M -99M -50M -120M
epsDiluted -2.77 -2.78 -2.09 -1.07 -2.7

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-31 2025-08-04 2024-11-05 2024-08-02 2024-05-03 2023-11-01 2023-08-02 2023-05-04 2022-11-04
acceptedDate 2025-10-30 18:53:18 2025-08-04 16:56:56 2025-02-24 18:11:53 2024-11-04 17:49:49 2024-08-02 16:44:58 2024-05-02 17:38:19 2024-02-23 17:23:59 2023-11-01 16:38:45 2023-08-02 16:53:09 2023-05-04 16:58:35 2023-02-24 17:27:48 2022-11-03 19:36:19 2022-02-28 16:35:09 2021-03-01 06:14:50
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 98M 101M 170M 100M 68M 42M 93M 109M 95M 76M 120M 104M 101M 97M
shortTermInvestments 175M 174M 149M 162M 194M 230M 202M 192M 209M 241M 233M 258M 313M 308M
cashAndShortTermInvestments 274M 275M 319M 262M 262M 273M 295M 301M 304M 318M 353M 362M 414M 404M
netReceivables 99M 83M 61M 56M 51M 47M 40M 39M 39M 38M 36M 35M 33M 36M
inventory 64M 65M 58M 60M 56M 50M 42M 40M 39M 40M 38M 34M 23M 16M
otherCurrentAssets 19M 14M 12M 19M 14M 19M 18M 20M 19M 20M 17M 18M 16M 13M
totalCurrentAssets 455M 436M 450M 397M 384M 389M 395M 400M 401M 416M 444M 449M 486M 469M
propertyPlantEquipmentNet 182M 184M 170M 168M 170M 172M 175M 175M 176M 171M 167M 161M 146M 95M
goodwill 67M 67M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M
intangibleAssets 264M 270M 263M 269M 276M 282M 283M 289M 295M 302M 308M 314M 333M 358M
goodwillAndIntangibleAssets 331M 337M 330M 336M 342M 348M 349M 355M 362M 368M 374M 380M 399M 424M
longTermInvestments 4M 4M 0 0 18M 18M 0 6M 0 0 7M 0 9M 10M
taxAssets 0 0 0 0 0 0 0 -6M 0 0 72M 0 79M 0
otherNonCurrentAssets 27M 25M 25M 25M 6M 6M 21M 19M 18M 18M 11M 19M 9M 7M
totalNonCurrentAssets 545M 551M 525M 529M 536M 545M 545M 549M 555M 557M 630M 560M 643M 536M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 999M 987M 975M 927M 920M 933M 940M 949M 957M 973M 1 074M 1 008M 1 129M 1 006M
accountPayables 20M 14M 13M 11M 12M 13M 13M 10M 9M 12M 14M 11M 7M 4M
shortTermDebt 0 0 2M 0 2M 0 0 0 0 0 430 000 0 1M 1M
taxPayables 0 0 0 2M 3M 7M 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 68M 65M 0 59M 53M 59M 21M 57M 55M 50M 36M 49M 34M 30M
totalCurrentLiabilities 88M 79M 75M 72M 70M 72M 74M 67M 64M 62M 72M 61M 63M 50M
longTermDebt 104M 105M 0 157M 157M 283M 283M 384M 384M 383M 281M 383M 280M 189M
deferredRevenueNonCurrent 0 0 0 0 100M 100M 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 7M 7M 7M 7M 7M 7M 7M 7M 7M 7M 79M 7M 86M 11M
otherNonCurrentLiabilities 31M 31M 22M 22M 21M 20M 14M 13M 13M 11M 10M 388M 9M 7M
totalNonCurrentLiabilities 142M 143M 133M 186M 184M 410M 405M 404M 404M 402M 472M 399M 478M 288M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 104M 105M 103M 100M 102M 100M 101M 101M 102M 101M 101M 101M 102M 81M
totalLiabilities 230M 222M 208M 258M 255M 483M 479M 471M 468M 464M 544M 460M 542M 338M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 57 000 57 000 56 000 55 000 55 000 50 000 49 000 49 000 48 000 48 000 48 000 48 000 47 000 45 000
retainedEarnings -799M -783M -745M -712M -690M -640M -599M -562M -532M -499M -464M -433M -365M -310M
accumulatedOtherComprehensiveIncomeLoss 3M 3M 3M 3M 2M 1M 1M 764 000 -387 000 -1M -3M -4M 15 000 1M
othertotalStockholdersEquity 1 566M 1 545M 1 378M 1 353M 1 089M 1 039M 1 021M 1 009M 985M
totalStockholdersEquity 770M 765M 767M 669M 665M 451M 462M 478M 489M 509M 530M 549M 587M 667M
totalEquity 770M 765M 767M 669M 665M 451M 462M 478M 489M 509M 530M 549M 587M 667M
totalLiabilitiesAndStockholdersEquity 999M 987M 927M 920M 933M 949M 957M 973M 1 008M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 999M 987M 975M 927M 920M 933M 940M 949M 957M 973M 1 074M 1 008M 1 129M 1 006M
totalInvestments 179M 178M 149M 162M 212M 249M 202M 192M 209M 241M 240M 258M 323M 317M
totalDebt 104M 105M 106M 157M 157M 384M 384M 384M 384M 383M 383M 383M 383M 272M
netDebt 6M 4M -64M 57M 89M 341M 290M 275M 289M 307M 263M 278M 283M 175M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-23 2023-02-24 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 61M 40M 36M 33M 36M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 13M 13M 14M 7M 4M
otherPayables 0 0 0 0 0
accruedExpenses 60M 40M 22M 21M 15M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 103M 101M 101M 102M 81M
treasuryStock -132 000 -132 000 -132 000 -132 000 -132 000
additionalPaidInCapital 1 510M 1 060M 997M 952M 977M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS GKOS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-31 2025-08-04 2024-11-05 2024-08-02 2024-05-03 2023-11-01 2023-08-02 2023-05-04 2022-11-04
acceptedDate 2025-10-30 18:53:18 2025-08-04 16:56:56 2025-02-24 18:11:53 2024-11-04 17:49:49 2024-08-02 16:44:58 2024-05-02 17:38:19 2024-02-23 17:23:59 2023-11-01 16:38:45 2023-08-02 16:53:09 2023-05-04 16:58:35 2023-02-24 17:27:48 2022-11-03 19:36:19 2022-02-28 16:35:09 2021-03-01 06:14:50
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -16M -20M -146M -21M -51M -41M -135M -30M -33M -35M -99M -28M -50M -120M
depreciationAndAmortization 10M 10M 40M 9M 8M 10M 38M 12M 7M 9M 36M 9M 34M 35M
deferredIncomeTax 11 000 -8000 -216 000 1000 -2000 0 -120 000 -9000 -1000 -5000 -54 000 -5000 -1M -12M
stockBasedCompensation 15M 18M 50M 14M 11M 11M 44M 10M 10M 10M 39M 9M 30M 46M
changeInWorkingCapital -16M -7M -39M -11M -8M -22M -10M 1M 246 000 -16M -13M -20M 4M -3M
accountsReceivables -19M -12M -22M -4M -5M -7M -4M -435 000 -1M -2M -3M 175 000 2M 2M
inventory 659 000 -3M -19M -3M -7M -9M -5M -620 000 806 000 -3M -15M -7M -8M 2M
accountsPayables 8M 7M 21 000 565 000 -1M -4M 1M 3M 0 2M 7M 0 12M -3M
otherWorkingCapital -5M 737 000 1M -4M 5M -3M -3M -1M 889 000 -14M -2M -13M -3M -5M
otherNonCashItems -3M 6M 35M -856 000 21M 59M 6M -884 000 7M 786 000 5M 3M 7M 32M
netCashProvidedByOperatingActivities -10M 7M -61M -10M -18M -34M -58M -8M -8M -31M -33M -27M 25M -23M
investmentsInPropertyPlantAndEquipment -2M -1M -6M -1M -2M -968 000 -20M -3M -6M -7M -30M -6M -48M -7M
acquisitionsNet 0 0 38 000 -38 000 38 000 0 0 0 0 531 000 151 000 0 3000 0
purchasesOfInvestments -75M -42M -190M -32M -42M -49M -266M -26M -73M -97M -59M -10M -215M -301M
salesMaturitiesOfInvestments 75M 54M 247M 65M 80M 22M 303M 42M 107M 90M 135M 41M 207M 105M
otherInvestingActivites -2M -32M -1M -1M -1M 2M -2M -531 000 0
netCashUsedForInvestingActivites -4M -21M 31M 35M -29M 15M 26M -14M 24M
debtRepayment -295 000 -278 000 -242 000 -226 000 -197 000 -190 000 -178 000 -149 000 -144 000
commonStockIssued 6M 5M 200M 0 16M 8M 0 675 000 0
commonStockRepurchased 0 0 0 2M -2M 5M 0 -768 000 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -649 000 -2M 10M 9M -2M 8M -702 000 626 000 4M
netCashUsedProvidedByFinancingActivities 5M 2M 10M 9M 13M 7M -880 000 1M 4M
effectOfForexChangesOnCash 6M -3M -2M 1M -630 000 -886 000 3M -79 000 282 000 317 000 870 000 -667 000 -2M -327 999
netChangeInCash -3M -14M 76M 37M 26M -51M -26M 14M 17M -43M 19M 1M 4M 34M
cashAtEndOfPeriod 98M 105M 170M 105M 68M 42M 93M 115M 101M 83M 120M 113M 101M 97M
cashAtBeginningOfPeriod 101M 119M 93M 68M 42M 93M 120M 101M 83M 127M 101M 112M 97M 62M
operatingCashFlow -10M 7M -61M -10M -18M -34M -58M -8M -8M -31M -33M -27M 25M -23M
capitalExpenditure -2M -1M -6M -1M -2M -968 000 -20M -3M -6M -7M -30M -6M -48M -7M
freeCashFlow -12M 6M -68M -11M -21M -35M -78M -12M -14M -38M -63M -33M -23M -30M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-23 2023-02-24 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -3M -3M -1M -2M -2M
netCashProvidedByInvestingActivities 48M 14M 45M -58M -205M
netDebtIssuance 51M -711 000 -527 000 -659 000 242M
longTermNetDebtIssuance 51M -711 000 -527 000 -659 000 242M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 47M 19M 9M 31M 24M
netCommonStockIssuance 47M 19M 9M 31M 24M
commonStockIssuance 47M 19M 9M 31M 24M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -7M -3M -2M 9M -4M
netCashProvidedByFinancingActivities 92M 15M 6M 39M 263M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-10-30 ET (fiscal 2025 q3)
2025 q2
2025-07-31 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-21 ET (fiscal 2024 q4)
2024 q3
2024-11-04 ET (fiscal 2024 q3)
2024 q2
2024-07-31 ET (fiscal 2024 q2)
2024 q1
2024-05-01 ET (fiscal 2024 q1)
2023 q4
2024-02-21 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-22 ET (fiscal 2022 q4)
2022 q3
2022-11-04 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-10-29 20:10 ET
Glaukos Corporation published news for 2025 q3
SEC form 8
2025-10-29 20:10 ET
Glaukos Corporation published news for 2025 q3
SEC form 8
2025-10-29 20:10 ET
Glaukos Corporation reported for 2025 q3
SEC form 8
2025-07-30 20:10 ET
Glaukos Corporation published news for 2025 q2
SEC form 8
2025-07-30 20:10 ET
Glaukos Corporation published news for 2025 q2
SEC form 8
2025-07-30 20:10 ET
Glaukos Corporation reported for 2025 q2
SEC form 10
2025-05-01 00:00 ET
Glaukos Corporation published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Glaukos Corporation published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Glaukos Corporation published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Glaukos Corporation reported for 2025 q1
SEC form 10
2025-02-25 00:00 ET
Glaukos Corporation published news for 2024 q4
SEC form 8
2025-02-20 16:10 ET
Glaukos Corporation published news for 2024 q4
SEC form 8
2025-02-20 16:10 ET
Glaukos Corporation published news for 2024 q4
SEC form 8
2025-02-20 16:10 ET
Glaukos Corporation reported for 2024 q4
SEC form 10
2024-11-04 17:49 ET
Glaukos Corporation published news for 2024 q3
SEC form 8
2024-11-04 16:10 ET
Glaukos Corporation published news for 2024 q3
SEC form 8
2024-11-04 16:10 ET
Glaukos Corporation published news for 2024 q3
SEC form 8
2024-11-04 16:10 ET
Glaukos Corporation published news for 2024 q3
SEC form 10
2024-08-02 00:00 ET
Glaukos Corporation published news for 2024 q2
SEC form 8
2024-07-31 16:10 ET
Glaukos Corporation published news for 2024 q2
SEC form 8
2024-07-31 16:10 ET
Glaukos Corporation published news for 2024 q2
SEC form 8
2024-07-31 16:10 ET
Glaukos Corporation reported for 2024 q2
SEC form 10
2024-05-03 00:00 ET
Glaukos Corporation published news for 2024 q1
SEC form 8
2024-05-01 16:10 ET
Glaukos Corporation published news for 2024 q1
SEC form 8
2024-05-01 16:10 ET
Glaukos Corporation published news for 2024 q1
SEC form 8
2024-05-01 16:10 ET
Glaukos Corporation reported for 2024 q1
SEC form 10
2024-02-23 00:00 ET
Glaukos Corporation published news for 2023 q4
SEC form 8
2024-02-21 16:10 ET
Glaukos Corporation published news for 2023 q4
SEC form 8
2024-02-21 16:10 ET
Glaukos Corporation published news for 2023 q4
SEC form 8
2024-02-21 16:10 ET
Glaukos Corporation reported for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Glaukos Corporation published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Glaukos Corporation published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Glaukos Corporation published news for 2023 q4
SEC form 10
2023-11-01 16:38 ET
Glaukos Corporation published news for 2023 q3
SEC form 8
2023-11-01 16:10 ET
Glaukos Corporation reported for 2023 q3
SEC form 10
2023-11-01 00:00 ET
Glaukos Corporation published news for 2023 q3
SEC form 10
2023-08-02 16:53 ET
Glaukos Corporation reported for 2023 q2
SEC form 6
2023-08-02 16:10 ET
Glaukos Corporation published news for 2023 q2
SEC form 10
2023-08-02 00:00 ET
Glaukos Corporation published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
Glaukos Corporation published news for 2023 q2
SEC form 6
2023-06-07 07:00 ET
Glaukos Corporation published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Glaukos Corporation published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Glaukos Corporation published news for 2023 q1
SEC form 6
2023-03-01 07:00 ET
Glaukos Corporation published news for 2022 q4
SEC form 10
2023-02-24 17:27 ET
Glaukos Corporation reported for 2022 q4
SEC form 10
2023-02-24 00:00 ET
Glaukos Corporation reported for 2022 q4
SEC form 6
2023-02-22 16:33 ET
Glaukos Corporation published news for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Glaukos Corporation reported for 2022 q4
SEC form 6
2023-01-10 16:15 ET
Glaukos Corporation published news for 2022 q4
SEC form 6
2022-12-21 16:36 ET
Glaukos Corporation published news for 2022 q3
SEC form 6
2022-11-15 07:00 ET
Glaukos Corporation published news for 2022 q3
SEC form 10
2022-11-04 00:00 ET
Glaukos Corporation reported for 2022 q3
SEC form 10
2022-11-03 19:36 ET
Glaukos Corporation reported for 2022 q3
SEC form 6
2022-11-02 16:11 ET
Glaukos Corporation published news for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Glaukos Corporation reported for 2022 q3
SEC form 6
2022-09-07 07:30 ET
Glaukos Corporation published news for 2022 q2
SEC form 10
2022-08-05 00:00 ET
Glaukos Corporation reported for 2022 q2
SEC form 10
2022-08-04 19:13 ET
Glaukos Corporation reported for 2022 q2
SEC form 6
2022-08-03 16:17 ET
Glaukos Corporation published news for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Glaukos Corporation reported for 2022 q2
SEC form 6
2022-06-08 16:16 ET
Glaukos Corporation published news for 2022 q1
SEC form 6
2022-05-23 08:01 ET
Glaukos Corporation published news for 2022 q1
SEC form 10
2022-05-05 17:26 ET
Glaukos Corporation reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Glaukos Corporation reported for 2022 q1
SEC form 6
2022-05-04 16:12 ET
Glaukos Corporation published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Glaukos Corporation reported for 2022 q1
SEC form 6
2022-04-19 16:54 ET
Glaukos Corporation published news for 2022 q1
SEC form 6
2022-04-05 20:44 ET
Glaukos Corporation published news for 2022 q1
SEC form 6
2022-04-05 20:40 ET
Glaukos Corporation published news for 2022 q1
SEC form 6
2022-03-02 16:50 ET
Glaukos Corporation published news for 2021 q4
SEC form 10
2022-02-28 16:35 ET
Glaukos Corporation published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Glaukos Corporation published news for 2021 q4
SEC form 6
2022-02-22 16:10 ET
Glaukos Corporation published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Glaukos Corporation published news for 2021 q4
SEC form 6
2022-02-07 16:20 ET
Glaukos Corporation published news for 2021 q4
SEC form 6
2022-01-11 16:16 ET
Glaukos Corporation published news for 2021 q4
SEC form 6
2021-12-20 16:20 ET
Glaukos Corporation published news for 2021 q3
SEC form 6
2021-11-22 07:00 ET
Glaukos Corporation published news for 2021 q3
SEC form 10
2021-11-08 17:21 ET
Glaukos Corporation published news for 2021 q3
SEC form 10
2021-11-08 00:00 ET
Glaukos Corporation published news for 2021 q3
SEC form 6
2021-11-04 16:18 ET
Glaukos Corporation published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Glaukos Corporation published news for 2021 q3
SEC form 6
2021-11-03 07:00 ET
Glaukos Corporation published news for 2021 q3
SEC form 6
2021-09-15 07:11 ET
Glaukos Corporation published news for 2021 q2
SEC form 6
2021-08-18 07:01 ET
Glaukos Corporation published news for 2021 q2
SEC form 10
2021-08-05 16:55 ET
Glaukos Corporation published news for 2021 q2
SEC form 6
2021-08-05 16:24 ET
Glaukos Corporation published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Glaukos Corporation published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Glaukos Corporation published news for 2021 q2
SEC form 6
2021-07-20 08:55 ET
Glaukos Corporation published news for 2021 q2
SEC form 6
2021-06-09 16:50 ET
Glaukos Corporation published news for 2021 q1
SEC form 10
2021-05-06 16:31 ET
Glaukos Corporation published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Glaukos Corporation published news for 2021 q1
SEC form 6
2021-05-05 16:20 ET
Glaukos Corporation published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Glaukos Corporation published news for 2021 q1
SEC form 6
2021-04-22 17:08 ET
Glaukos Corporation published news for 2021 q1
SEC form 6
2021-03-04 07:01 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-03-03 17:42 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-03-03 17:40 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-03-01 16:59 ET
Glaukos Corporation published news for 2020 q4
SEC form 10
2021-03-01 06:14 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-02-25 16:16 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-01-13 07:10 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-01-06 21:30 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-01-06 21:30 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-01-06 21:30 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-01-06 21:30 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2021-01-06 21:29 ET
Glaukos Corporation published news for 2020 q4
SEC form 6
2020-12-18 21:15 ET
Glaukos Corporation published news for 2020 q3
SEC form 6
2020-12-18 20:41 ET
Glaukos Corporation published news for 2020 q3
SEC form 6
2020-12-18 20:40 ET
Glaukos Corporation published news for 2020 q3
SEC form 6
2020-11-20 16:47 ET
Glaukos Corporation published news for 2020 q3
SEC form 6
2020-11-10 16:49 ET
Glaukos Corporation published news for 2020 q3
SEC form 10
2020-11-05 16:54 ET
Glaukos Corporation published news for 2020 q3
SEC form 6
2020-11-05 16:21 ET
Glaukos Corporation published news for 2020 q3